+10000000)+'&millis='+new Date().getTime()+'&zid=472&referrer='+encodeURIComponent(document.location)+')
The U.S. Food and Drug Administration (FDA) Nov. 19 approved Navigator for treating equine protozoal myeloencephalitis (EPM). This drug has been under development for more than six years.
Friday, December 05, 2003+10000000)+'&millis='+new Date().getTime()+'&zid=473&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=476&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=441&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=366&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=466&referrer='+encodeURIComponent(document.location)+')
Copyright © 2012 Blood-Horse Publications. All rights reserved internationally.
+10000000)+'&millis='+new Date().getTime()+'&zid=601&referrer='+encodeURIComponent(document.location)+')